NCT01422187View on ClinicalTrials.gov

A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

September 30, 2014

Conditions

Gaucher Disease

Interventions

DRUG

Taliglucerase alfa

Taliglucerase infusion every two weeks for 21 months

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01422187 - A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease | Biotech Hunter | Biotech Hunter